Synexus Chooses Rockbrook Village for its next Omaha Location
Synexus is set to open its newest site in Rockbrook Village. This will be the sixth location in the greater Omaha area for the clinical trial research company. Regional Director, Amy Isaacson explains, “We chose Rockbrook for our newest location because of its vitality, energy, as well as its reputation as a community center; that, paired with its central location made it the perfect fit for our next site.”
Synexus, a globally operated company, brings access to new therapies and treatment innovations with studies that range from treating migraines, osteoarthritis, hypertension, to high cholesterol, diabetes, vaccinations, and more. “While the end goal is to contribute to the advancement of science, we manage to differentiate ourselves from competitors by placing an emphasis on the patient experience and providing an individualized healthcare experience during participation in our clinical trials,” says Isaacson. Synexus facilities are able to achieve this by employing a full-time research staff that is dedicated to ensuring a safe and quality experience for each trial participant.
“We welcome all community members who are interested in learning more about and participating in clinical research studies to stop by and meet our staff, ask questions, and hear about our currently available clinical trials,” adds Dr. Jennifer Kay, a board certified family medicine physician, who will lead the research team at their Rockbrook Village Location.
The Greater Omaha Chamber of Commerce will be sponsoring Synexus’ grand opening and ribbon cutting on Friday, November 10th from 2-6 pm. Synexus welcomes the greater Omaha community to come help them celebrate the opening on Friday.
For more information please contact Amy Isaacson at 402.205.7998 or Amy.Isaacson@synexus-us.com